OXIS International Inc. (OXISD) Downgraded to Sell at ValuEngine

OXIS International Inc. (OTCMKTS:OXISD) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Friday, September 1st.

Shares of OXIS International (OTCMKTS:OXISD) opened at 6.00 on Friday. OXIS International has a 12-month low of $3.00 and a 12-month high of $78.70. The firm’s market cap is $298.61 million.

WARNING: This piece was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://ledgergazette.com/2017/09/17/oxis-international-inc-oxisd-downgraded-by-valuengine-to-sell.html.

About OXIS International

GT Biopharma, Inc, formerly OXIS International, Inc, is an immuno-oncology company. The Company is engaged in discovering, developing and commercializing therapeutics from its product platform in a range of disease areas. The Company develops drugs focused on the treatment of cancer. Its technology platform consists of bispecific and trispecific single-chain variable fragment (scFv) constructs, full-length antibodies, drug payloads, antibody-drug linkers, dual-drug payload antibody-drug conjugates (ADCs), bispecific targeted ADCs, and natural killer cell and T lymphocyte antibody directed cell-mediated cytotoxic (ADDCs) agents.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for OXIS International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OXIS International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply